Brief: ELEVAI Labs Subsidiary, Elevai Skincare Announces Positive Results For E-Series Exosome Technology In Potential Melasma Applications
10/09/2024 13:24
Sept 10 (Reuters) - Elevai Labs Inc ELAB.O :
* ELEVAI LABS INC SUBSIDIARY, ELEVAI SKINCARE INC ANNOUNCES
POSITIVE RESULTS FOR E-SERIES EXOSOME TECHNOLOGY IN POTENTIAL
MELASMA APPLICATIONS
* ELEVAI LABS-EARLY RESULTS SHOW SYNERGISTIC EFFECTS OF
ELEVAI
EXOSOMES, LASER TREATMENTS FOR MELASMA IMPROVEMENT WITH NO
RECURRENCE AFTER 6 MONTHS
Source text for Eikon: ID:nGNX6NcdKW
Further company coverage: ELAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PMGC Holdings
See all newsBrief: PMGC Announces DBA As NorthStrive Holdings Trademark License Agreement, & Website Update
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
Pmgc Holdings Rises As Unit Expands Rights To Ai: discovered obesity, heart disease drug program